Table 1.

Patient Characteristics at Initial Diagnosis

Age Groups	<= 50Years	22(40.7%)
	>50 Years	32(59.3%)
Gender	Male	38 (70%)
	Female	16 (30%)
B Symptoms	Yes	34 (63%)
	No	20 (37%)
Stage	Stage I / II	3 (06%) /17 (32%)
	Stage III / IV	11 (20%)/23 (43%)
RIPI	RIPI I / II	11 (20%)/24 (44%)
	RIPI III / IV	14 (26%)/5 (09%)

SD, standard deviation; RIPI, rituximab International Prognostic Index